Phase 4
Completed N=86
Nonopioid Pain Control Regimen After Arthroscopic Hip Procedures
Hip Arthroscopy
Source: ClinicalTrials.gov NCT05076110 ↗
Enrolled (actual)
86
Serious AEs
0.0%
Results posted
Jun 2026
Primary outcomePrimary: Change in Pain Score — 4.3; 4.4; 1.8; 1.7 score on a scale
◆ Published Evidence
No publication linked
No peer-reviewed publication reporting this trial's results has been linked yet. This can indicate results are unpublished — a known publication-bias signal. We re-check periodically.
Summary
This study is being conducted to evaluate the effectiveness of post-operative pain control without using narcotic pain medications.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Change in Pain Score |
4.3; 4.4; 1.8; 1.7 | — |
| SECONDARY Change in Patient Reported Outcomes Measurement Information System (PROMIS) Pain Interference Score |
61.0; 62.7; 52.3; 53.4 | — |
| SECONDARY Change in Opioid Consumption |
10.9; 0.1 | — |
Eligibility Criteria
Inclusion Criteria
- Scheduled for a primary Hip Arthroscopy at Mayo Clinic (Rochester, MN)
Exclusion Criteria
- medical history of known allergies or intolerance to allergies or intolerance to Motrin, Gabapentin, Tylenol, dexamethasone, tramadol, or Robaxin.
- Substantial alcohol or drug abuse.
- History of narcotics within 6 months of surgery.
- Pregnancy.
- Renal impairment.
- Peptic ulcer disease.
- GI bleeding.
Data sourced from ClinicalTrials.gov (NCT05076110). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.